✦ LIBER ✦

Efficacy and safety of exenatide administered before the two largest daily meals of Latin American patients with type 2 diabetes*

✍ Scribed by Forti, Adriana; Garcia, Eduardo Garcia; Yu, Maria B.; Jimenez, Maria C.; Brodows, Robert G.; Oliveira, Juliana H.

Book ID: 119966592
Publisher: Informa plc
Year: 2008
Tongue: English
Weight: 174 KB
Volume: 24
Category: Article
ISSN: 0300-7995
DOI: 10.1185/03007990802282398

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and efficacy of twice-daily exena

Safety and efficacy of twice-daily exenatide in Taiwanese patients with inadequately controlled type 2 diabetes mellitus

✍ Lu, Chieh-Hsiang; Wu, Ta-Jen; Shih, Kuang-Chung; Ni, Ewan; Reed, Victoria; Yu, M 📂 Article 📅 2013 🏛 Chinese Electronic Periodical Services 🌐 English ⚖ 307 KB

Long-term safety and efficacy of exenati

Long-term safety and efficacy of exenatide twice daily in Japanese patients with suboptimally controlled type 2 diabetes

✍ Nobuya Inagaki; Kohjiro Ueki; Ayuko Yamamura; Hitoshi Saito; Takeshi Imaoka 📂 Article 📅 2011 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 295 KB

Safety and Efficacy of Once-Weekly Exena

Safety and Efficacy of Once-Weekly Exenatide Compared With Insulin Glargine Titrated to Target in Patients With Type 2 Diabetes Over 84 Weeks

✍ Diamant, M.; Van Gaal, L.; Stranks, S.; Guerci, B.; MacConell, L.; Haber, H.; Sc 📂 Article 📅 2012 🏛 American Diabetes Association 🌐 English ⚖ 740 KB

Efficacy and safety of the once-daily hu

Efficacy and safety of the once-daily human GLP-1 analogue, liraglutide, vs glibenclamide monotherapy in Japanese patients with type 2 diabetes

✍ Seino, Y.; Rasmussen, M.F.; Nishida, T.; Kaku, K. 📂 Article 📅 2010 🏛 Informa plc 🌐 English ⚖ 599 KB

Once-Weekly Exenatide Versus Once- or Tw

Once-Weekly Exenatide Versus Once- or Twice-Daily Insulin Detemir: Randomized, open-label, clinical trial of efficacy and safety in patients with type 2 diabetes treated with metformin alone or in combination with sulfonylureas

✍ Davies, M.; Heller, S.; Sreenan, S.; Sapin, H.; Adetunji, O.; Tahbaz, A.; Vora, 📂 Article 📅 2012 🏛 American Diabetes Association 🌐 English ⚖ 223 KB

Safety and efficacy of switching thrice-

Safety and efficacy of switching thrice-daily treatment with NovoRapid®70Mix (BIAsp70) to BIAsp70 before breakfast and lunch and NovoRapid®30Mix (BIAsp30) before dinner in patients with type 2 diabetes: subgroup analysis of a phase III trial

✍ Takashi Kadowaki; Tomoyuki Nishida; Kohei Kaku 📂 Article 📅 2011 🏛 Springer Japan 🌐 English ⚖ 317 KB